Clofarabine in Chronic Lymphocytic Leukemia
NCT00028418
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Neoplasms
Lymphoproliferative Disorders
Leukemia
Leukemia, Lymphocytic, Chronic
Interventions
DRUG:
Clofarabine
Sponsor
M.D. Anderson Cancer Center